Search research articles
Contact Us
Filters
Showing results (51-60 of 212) with videos related to
Page
of 22
Sort By:
European Journal of Cancer
|
January 1, 1975
Herpes zoster-varicella infection in malignant lymphomas. Influence of splenectomy and intensive treatment
S Monfardini, E Bajetta, C A Arnold, et al.
Tumori
|
June 30, 1993
Subcutaneous low-dose interleukin-2 plus alpha interferon in advanced malignant melanoma
F de Braud, L Biganzoli, E Bajetta, et al.
Tumori
|
August 12, 2000
Ovarian ablation for premenopausal early-stage breast cancer: an update
L Celio, E Bajetta, L Toffolatti, et al.
Tumori
|
October 31, 1984
Monoclonal gammopathy (IgM-k) in a patient with Burkitt's type lymphoblastic lymphoma
E Bajetta, G Gasparini, G Facchetti, et al.
American Journal of Clinical Oncology
|
October 1, 1985
Prospective randomized trial in advanced malignant melanoma with cis-platinum, vindesine, and etoposide vs. cis-platinum, vindesine, and lomustine
E Bajetta, R Buzzoni, S Viviani, et al.
Tumori
|
February 28, 1986
Fine needle percutaneous intratumoral chemotherapy under ultrasound guidance: a feasibility study
T Livraghi, E Bajetta, L Matricardi, et al.
Cancer
|
November 1, 1977
Sequential pathologic staging of untreated non-Hodgkin's lymphomas by laparoscopy and laparotomy combined with marrow biopsy
R Castellani, G Bonadonna, P Spinelli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 2, 2001
Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: results of a randomized, double-blind, placebo-controlled trial
T J Littlewood, E Bajetta, J W Nortier, et al.
Digestion
|
January 1, 1996
The role of somatostatin analogues in the treatment of gastro-enteropancreatic endocrine tumours
E Bajetta, C Carnaghi, L Ferrari, et al.
Tumori
|
May 1, 1973
[Polychemotherapy with 5-(3,3 dimethyl-1-triazeno)imidazole-4-carboxamide (DTIC; NSC-45388), 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU, NSC-409962) and vincristine (NSC-67574) in the metastatic phase of melanoma]
G Beretta, E Bajetta, G Bonadonna, et al.
Page
of 22
Search research articles
Search
Showing results (51-60 of 212) with videos related to
Sort By:
Page
of 22
European Journal of Cancer
|
January 1, 1975
Herpes zoster-varicella infection in malignant lymphomas. Influence of splenectomy and intensive treatment
S Monfardini, E Bajetta, C A Arnold, et al.
Tumori
|
June 30, 1993
Subcutaneous low-dose interleukin-2 plus alpha interferon in advanced malignant melanoma
F de Braud, L Biganzoli, E Bajetta, et al.
Tumori
|
August 12, 2000
Ovarian ablation for premenopausal early-stage breast cancer: an update
L Celio, E Bajetta, L Toffolatti, et al.
Tumori
|
October 31, 1984
Monoclonal gammopathy (IgM-k) in a patient with Burkitt's type lymphoblastic lymphoma
E Bajetta, G Gasparini, G Facchetti, et al.
American Journal of Clinical Oncology
|
October 1, 1985
Prospective randomized trial in advanced malignant melanoma with cis-platinum, vindesine, and etoposide vs. cis-platinum, vindesine, and lomustine
E Bajetta, R Buzzoni, S Viviani, et al.
Tumori
|
February 28, 1986
Fine needle percutaneous intratumoral chemotherapy under ultrasound guidance: a feasibility study
T Livraghi, E Bajetta, L Matricardi, et al.
Cancer
|
November 1, 1977
Sequential pathologic staging of untreated non-Hodgkin's lymphomas by laparoscopy and laparotomy combined with marrow biopsy
R Castellani, G Bonadonna, P Spinelli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 2, 2001
Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving nonplatinum chemotherapy: results of a randomized, double-blind, placebo-controlled trial
T J Littlewood, E Bajetta, J W Nortier, et al.
Digestion
|
January 1, 1996
The role of somatostatin analogues in the treatment of gastro-enteropancreatic endocrine tumours
E Bajetta, C Carnaghi, L Ferrari, et al.
Tumori
|
May 1, 1973
[Polychemotherapy with 5-(3,3 dimethyl-1-triazeno)imidazole-4-carboxamide (DTIC; NSC-45388), 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU, NSC-409962) and vincristine (NSC-67574) in the metastatic phase of melanoma]
G Beretta, E Bajetta, G Bonadonna, et al.
Page
of 22